Clinical Trials Logo

Acne Vulgaris clinical trials

View clinical trials related to Acne Vulgaris.

Filter by:

NCT ID: NCT02682264 Completed - Acne Vulgaris Clinical Trials

An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris

Start date: March 9, 2016
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to determine the long-term safety of CB-03-01 cream, 1% applied twice daily for an additional nine months in study participants with acne vulgaris that participated in the Phase 3 pivotal studies for a total treatment of up to 12 months.

NCT ID: NCT02672332 Completed - Acne Vulgaris Clinical Trials

P3 Study in Acne Comparing Once Daily SB204 and Vehicle

Start date: February 22, 2016
Phase: Phase 3
Study type: Interventional

This is a 12 week, multi-center, double-blinded, randomized, vehicle-controlled, parallel group, study to be conducted in approximately 1300 subjects with acne vulgaris in the US.

NCT ID: NCT02667444 Completed - Acne Vulgaris Clinical Trials

P3 Study Comparing Once Daily SB204 and Vehicle Gel in Acne

Start date: February 19, 2016
Phase: Phase 3
Study type: Interventional

This is a 12 week, multi-center, double-blinded, randomized, vehicle-controlled, parallel group, study to be conducted in approximately 1300 subjects with acne vulgaris in the US.

NCT ID: NCT02661958 Completed - Acne Vulgaris Clinical Trials

Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris

Start date: May 2016
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the superiority in efficacy and assess safety and tolerability of the products S6G5T-3 and S6G5T-1 as compared to their respective active components or the vehicle for the treatment of acne.

NCT ID: NCT02656485 Completed - Acne Vulgaris Clinical Trials

A Double Blind, Placebo-Controlled, Randomized Study in Subjects With Acne Vulgaris

Start date: August 5, 2015
Phase: Phase 1/Phase 2
Study type: Interventional

This is a single center, randomized, double-blind, placebo-controlled study in subjects with acne vulgaris.

NCT ID: NCT02656043 Completed - Acne Vulgaris Clinical Trials

A Safety, Tolerability, Efficacy and Exposure Study of XEN801 Topical Gel

Start date: September 17, 2015
Phase: Phase 1/Phase 2
Study type: Interventional

Phase 1/2 study enrolling up to 60 healthy volunteers in Phase 1 followed by approximately 150 subjects with acne vulgaris in Phase 2.

NCT ID: NCT02651012 Withdrawn - Acne Vulgaris Clinical Trials

Study to Evaluate the Efficacy and Safety of 1.5 mg/kg/Day of Sarecycline vs Placebo in the Treatment of Acne Vulgaris

SC1401
Start date: March 2015
Phase: Phase 3
Study type: Interventional

A Study to Evaluate the Efficacy and Safety Sarecycline in the Treatment of Acne Vulgaris.

NCT ID: NCT02647528 Withdrawn - Acne Vulgaris Clinical Trials

A Trial of Pulse Dyed Laser (Chromogenex Regenlite Transform) in the Treatment of Inflammatory Acne Vulgaris

Chromogenix
Start date: March 2016
Phase: Phase 4
Study type: Interventional

A Randomized, Blinded, Single-Centered, Placebo-Controlled Trial of Pulse Dyed Laser (Chromogenex Regenlite Transform) in the Treatment of Inflammatory Acne Vulgaris

NCT ID: NCT02646917 Completed - Atrophic Acne Scar Clinical Trials

SkinPen Efficacy on Acne Scars on the Face and/or Back

Start date: December 2015
Phase: N/A
Study type: Interventional

This single-center, clinical trial will take place over a 90 day course followed by 1-month and 6-month post treatment visits to assess the efficacy and tolerability of the SkinPen device when used on both men and women on the face and/or back.

NCT ID: NCT02643628 Completed - Atrophic Acne Scars Clinical Trials

A Pilot Study to Evaluate the Safety and Effectiveness of Microneedling and Bellafill to Treat Facial Acne Scars

Start date: October 10, 2015
Phase: N/A
Study type: Interventional

This is an open-label, randomized, multicenter, prospective trial assessing the efficacy and safety of microneedling treatment alone vs. microneedling treatment followed by treatment with Bellafill for correction of distensible atrophic facial acne scars.